Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07575932
PHASE2

A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)

Sponsor: Pfizer

View on ClinicalTrials.gov

Summary

This study is being done to learn about the safety and effects of the study drugs, PF-08653945 and PF-08653944, when given alone or together for weight loss, compared to a placebo (a dummy drug that has no active ingredient in it).

Official title: A PHASE 2B, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, DOSE RANGING, DOSE-FINDING, UMBRELLA STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-08653945 AND PF-08653944, ALONE OR IN COMBINATION, IN ADULTS WITH OVERWEIGHT OR OBESITY (SOLIS-1)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

872

Start Date

2026-05-11

Completion Date

2028-01-05

Last Updated

2026-05-08

Healthy Volunteers

No

Interventions

DRUG

PF-08653945

Subcutaneous Injection

DRUG

PF-08653944

Subcutaneous Injection

DRUG

Placebo

Subcutaneous Injection

Locations (3)

Ark Clinical Research

Fountain Valley, California, United States

Paragon Rx Clinical

Garden Grove, California, United States

Koch Family Medicine Clinical Research/Elite Research Network

Morton, Illinois, United States